由RTW Investments携手泉创资本（Quan Capital）举办的“Meet with RTW: Innovation Is the Best Medicine”线下闭门会将于2026年6月26日下午13:30在上海举行，诚邀biotech/pharma公司的同道莅临！
RTW基金，作为总部在纽约的全球顶尖、科学驱动、全周期的生物医药投资基金，管理近100亿美元，深耕创新药与前沿疗法，兼具医疗专业度与长期资本耐心，成为海内外biotech打通融资渠道，落地海外临床与商业化的首选合作伙伴。
本次闭门交流会落地上海，RTW联合泉创资本（Quan Capital），一家全球范围内专注于生命科学领域的知名创投基金，携手国内创新药企高管，结合全球投融资实战案例，拆解创新药不同研发阶段的融资逻辑、海外管线授权合作要点，帮助本土创新药企打通走向全球市场的关键链路。
期待与您面对面交流，共同探讨跨境创新与产业协同的新机遇。席位有限，敬请尽快通过下方通道完成注册。审核通过视为报名成功。会议详细地址请见报名成功邮件通知和短信。
About RTW
Founded in 2009, RTW Investments is a top-tier global life sciences investment institution headquartered in New York, with offices in London, Shanghai and other locations. With AUM close to $10B, it specializes in full-lifecycle biotech investment from startup incubation to public equity, driven by a science-first investment team of clinicians and industry veterans.
Focused on breakthrough therapies for unmet medical needs across oncology, immunology and other key therapeutic sectors, RTW provides both capital and hands-on operational support to portfolio firms, helping global and Chinese biotech startups optimize clinical development and realize cross-border commercialization, in line with its core philosophy: Innovation Is the Best Medicine.
About Quan Capital
Quan Capital is a life sciences venture capital firm with strong China expertise and global capabilities. The firm discovers, incubates and grows next-generation life science companies in early and growth stage, worldwide. Quan’s portfolio companies pioneer differentiated therapies and enabling technologies to address major human diseases with high unmet medical needs. Quan has offices in Shanghai and Palo Alto. The firm’s investment professionals combine their strong expertise in both science and business with their diverse experiences in global drug development and healthcare investments, and they leverage their broad network worldwide to help maximize the company’s value across geographies and development stages. Visit www.quancapital.com to learn more.